Dr. Adeel M. Popalzai, DO

Dr. Popalzai practices at Pomona Valley Hospital Medical Center in Pomona, California, part of Pomona Valley Hospital Medical Center.

Dr. Popalzai's NPI, 1558508663, was assigned on January 12, 2009. Dr. Popalzai graduated from WesternU College of Osteopathic Medicine of the Pacific in 2007. Dr. Popalzai holds California license 20A10930.

Dr. Popalzai's primary practice is Pomona Valley Hospital Medical Center, at 1798 N Garey Ave, Pomona, CA 91767 in Los Angeles County. The practice phone is (909) 865-9500.

Dr. Popalzai's primary practice is Pomona Valley Hospital Medical Center in Pomona, California, part of Pomona Valley Hospital Medical Center. Dr. Popalzai is also affiliated with Casa Colina Hospital and Centers for Healthcare. The medical group on file is The Neurology Group. Dmand AI also links Dr. Popalzai to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Popalzai practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Popalzai's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Popalzai is board certified in neurology by the AOA Board of Neurology and Psychiatry. Dmand AI has Dr. Popalzai's licenses on file in 2 states: California and Arizona.

Dmand AI lists cerebrovascular disease, epilepsy and parkinson's disease among the conditions Dr. Popalzai treats.

CMS data shows 2,464 Medicare services from Dr. Popalzai across 8 procedure codes in 2024, for 658 Medicare patients. Medicare paid $248,529 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 658 Medicare patients who saw Dr. Popalzai in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Popalzai's median patient age at 68, with 49% women.

In 2023, Dr. Popalzai wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $19,022 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Popalzai for performance year 2024, reported individually. Dr. Popalzai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Popalzai in 2014. Dr. Popalzai's most frequent co-author is Lucas Ramirez, MD.

CMS Open Payments shows 78 general payments to Dr. Popalzai from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. LivaNova PLC paid the most, $1,178. It also lists 2 research payments totaling $100 from 2017 to 2018.

Dr. Popalzai graduated from WesternU College of Osteopathic Medicine of the Pacific in 2007. Dr. Popalzai is a member of AOA.

Dr. Popalzai is in network with 9 carriers, including Elevance, Blue Cross Blue Shield of Michigan and LA Care. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.